Fig. 2From: Investigation of the impact of SARS-CoV infection on the immunologic status and lung function after 15 yearsPeripheral T cell subsets between SARS survivors and healthy controls. The proportion of CD4 + (A), CD8 + (B), CD4 + CD25 + (C) and CD4 + CD25 + Foxp3 + regulatory T cells (D) between SARS survivors and healthy controlsBack to article page